• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导痰:当前进展与展望

Induced sputum: current progress and prospect.

作者信息

Zhang Fuyun, Wang Huanhuan, Wang Wei, Zhu Yingwei, Mao Yimin, Wang Tongsheng, Gao Pengfei

机构信息

Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, Henan, China.

Department of Respiratory and Critical Care Medicine, People's Hospital of Zhengzhou, Zhengzhou, Henan, China.

出版信息

Eur J Med Res. 2025 Aug 25;30(1):795. doi: 10.1186/s40001-025-02974-w.

DOI:10.1186/s40001-025-02974-w
PMID:40855337
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12376322/
Abstract

Induced sputum is a noninvasive, safe, cost-effective, and reproducible method that is particularly advantageous for individuals who do not naturally produce sputum or provide inadequate samples. Its higher quality than spontaneously produced sputum makes it valuable in various respiratory conditions such as chronic obstructive pulmonary disease, asthma, lung cancer, and infectious respiratory diseases. Despite its potential, the clinical use of induced sputum is limited. In conditions like interstitial lung disease, where patients often have a dry cough, induced sputum shows promise, albeit with limited research. This review emphasizes the usefulness of induced sputum in such conditions, aiming for induced sputum to be established as a routine supplementary examination in clinical settings.

摘要

诱导痰是一种非侵入性、安全、经济高效且可重复的方法,对于那些自然咳痰不足或无法咳痰的个体尤为有利。其质量高于自然咳出的痰液,这使其在慢性阻塞性肺疾病、哮喘、肺癌和传染性呼吸道疾病等各种呼吸道疾病中具有重要价值。尽管诱导痰具有潜力,但在临床中的应用仍然有限。在间质性肺疾病等患者常伴有干咳的情况下,诱导痰虽研究有限,但显示出了应用前景。本综述强调了诱导痰在此类疾病中的有用性,旨在使诱导痰成为临床常规的辅助检查手段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf8/12376322/bfeb1662eb62/40001_2025_2974_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf8/12376322/bfeb1662eb62/40001_2025_2974_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bf8/12376322/bfeb1662eb62/40001_2025_2974_Fig1_HTML.jpg

相似文献

1
Induced sputum: current progress and prospect.诱导痰:当前进展与展望
Eur J Med Res. 2025 Aug 25;30(1):795. doi: 10.1186/s40001-025-02974-w.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].[支气管哮喘防治指南(2024年版)]
Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601.
4
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.用于指导慢性阻塞性肺疾病急性加重期抗生素自我治疗的痰液颜色图表:Colour-COPD随机对照试验
Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558.
5
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
6
Leveraging AI and Machine Learning to Develop and Evaluate a Contextualized User-Friendly Cough Audio Classifier for Detecting Respiratory Diseases: Protocol for a Diagnostic Study in Rural Tanzania.利用人工智能和机器学习开发并评估用于检测呼吸道疾病的情境化用户友好型咳嗽音频分类器:坦桑尼亚农村地区的一项诊断性研究方案
JMIR Res Protoc. 2024 Apr 23;13:e54388. doi: 10.2196/54388.
7
Clinical characteristics of the asthma-COPD overlap syndrome--a systematic review.哮喘-慢性阻塞性肺疾病重叠综合征的临床特征——一项系统综述
Int J Chron Obstruct Pulmon Dis. 2015 Jul 27;10:1443-54. doi: 10.2147/COPD.S85363. eCollection 2015.
8
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
9
Pain Assessment疼痛评估
10
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.Xpert MTB/RIF Ultra assay 用于儿童结核病和利福平耐药检测。
Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD013359. doi: 10.1002/14651858.CD013359.pub3.

本文引用的文献

1
GOLD COPD report: 2025 update.慢性阻塞性肺疾病全球倡议(GOLD)报告:2025年更新版
Lancet Respir Med. 2025 Jan;13(1):e7-e8. doi: 10.1016/S2213-2600(24)00413-2. Epub 2024 Dec 5.
2
Interstitial Lung Disease: A Review.间质性肺疾病:综述。
JAMA. 2024 May 21;331(19):1655-1665. doi: 10.1001/jama.2024.3669.
3
Exploring Inflammatory Asthma Phenotypes: Proteomic Signatures in Serum and Induced Sputum.探讨炎症性哮喘表型:血清和诱导痰中的蛋白质组学特征。
Int J Mol Sci. 2024 Mar 20;25(6):3501. doi: 10.3390/ijms25063501.
4
Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.慢性呼吸系统疾病中的黏液结构、黏弹性特性和成分。
Int J Mol Sci. 2024 Feb 5;25(3):1933. doi: 10.3390/ijms25031933.
5
Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent Asthma.痰嗜酸性粒细胞与未经治疗的轻度持续性哮喘中易于测量的 2 型炎症生物标志物的关联。
J Allergy Clin Immunol Pract. 2024 Apr;12(4):960-969.e6. doi: 10.1016/j.jaip.2023.12.010. Epub 2023 Dec 12.
6
Sputum induction and its diagnostic applications in inflammatory airway disorders: a review.痰液诱导及其在炎症性气道疾病中的诊断应用:综述
Front Allergy. 2023 Oct 12;4:1282782. doi: 10.3389/falgy.2023.1282782. eCollection 2023.
7
Methodological Aspects of Induced Sputum.诱导痰的方法学方面。
Adv Respir Med. 2023 Sep 27;91(5):397-406. doi: 10.3390/arm91050031.
8
Stratification of asthma by lipidomic profiling of induced sputum supernatant.通过诱导痰上清液的脂质组学分析对哮喘进行分层。
J Allergy Clin Immunol. 2023 Jul;152(1):117-125. doi: 10.1016/j.jaci.2023.02.032. Epub 2023 Mar 12.
9
Asthma inflammatory phenotypes on four continents: most asthma is non-eosinophilic.四大洲的哮喘炎症表型:多数哮喘是非嗜酸性粒细胞性的。
Int J Epidemiol. 2023 Apr 19;52(2):611-623. doi: 10.1093/ije/dyac173.
10
Interstitial lung diseases.间质性肺疾病
Lancet. 2022 Sep 3;400(10354):769-786. doi: 10.1016/S0140-6736(22)01052-2. Epub 2022 Aug 11.